Correction of a release from 23.05.2013, 11:40 CET - STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

08.10.2014 14:26

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Correction of release dated 23 May 2013


1. Threadneedle Asset Management Holdings Limited

On 6 October 2014 Threadneedle Asset Management Holdings Limited, London, UK, has sent us the following correction of their voting rights notification dated 22 May 2013:

Threadneedle Asset Management Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights). Threadneedle Asset Management Holdings Limited has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to Threadneedle Asset Management Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


2. Threadneedle Asset Management Limited

On 6 October 2014 Threadneedle Asset Management Limited, London, UK, has sent us the following correction of their voting rights notification dated 22 May 2013:

Threadneedle Asset Management Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights). Threadneedle Asset Management Limited has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to Threadneedle Asset Management Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.
The voting rights were attributed to Threadneedle Asset Management Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


08.10.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back